BOSTON (AP) _ Vertex Pharmaceuticals Inc. (VRTX) on Wednesday reported fourth-quarter profit of $770.1 million.

On a per-share basis, the Boston-based company said it had profit of $3. Earnings, adjusted for one-time gains and costs, came to $3.37 per share.

The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $3.28 per share.

The drugmaker posted revenue of $2.07 billion in the period, which also beat Street forecasts. Eight analysts surveyed by Zacks expected $1.99 billion.

For the year, the company reported profit of $2.34 billion, or $9.01 per share. Revenue was reported as $7.57 billion.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VRTX at https://www.zacks.com/ap/VRTX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News